Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Diabetes

PUBLISHER: Grand View Research | PRODUCT CODE: 1405866

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1405866

Diabetic Retinopathy Market Size, Share & Trends Analysis Report By Type (Proliferative DR, Non-Proliferative DR), By Management (Anti-VEGF Therapy, Intraocular Steroid Injection, Laser Surgery, Vitrectomy), By Region, & Segment Forecasts, 2024-2030

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Diabetic Retinopathy Market Growth & Trends:

The global diabetic retinopathy market size is anticipated to reach USD 13.77 billion by 2030 and is anticipated to expand at a CAGR of 6.43% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising prevalence of diabetes, growing geriatric population, and increasing prevalence of blindness due to diabetes are the major factors anticipated to boost market growth over the forecast period. Growth in the market is further propelled by the increasing awareness about diabetes management & care and new product launches. Diabetic retinopathy is caused by damage to the blood vessels in the retina, which leads to blurred vision and vision loss in most cases.

The increase in prevalence of diabetes due to aging, obesity, and unhealthy lifestyles is contributing to the growth of the market. Obesity is a major factor leading to diabetes. According to WHO, in 2021, around 39% of adults aged 18 years and above were overweight, and 13% were obese worldwide. In addition to obesity, diabetes is becoming increasingly prevalent globally. The International Diabetes Federation (IDF) estimated l537 million adults (aged 20 to 79 years) were living with diabetes in 2021, which is expected to rise to 642 million by 2040. The IDF also reports that the prevalence of diabetes is increasing globally, with the highest increases witnessed in low- and middle-income countries. In 2021, the regions with the highest number of adults living with diabetes were the Western Pacific (167 million), South Asia (88 million), and Europe (59 million).

The rising geriatric population is a significant driver of the diabetes epidemic, as diabetes in older people is directly linked with higher mortality and reduced functional status. According to WHO, 80% of older people are expected to live in low- and middle-income nations by 2050. The population is aging at a considerably higher rate than in the past. In 2020, the number of persons aged 60 years and more will outnumber children under the age of 5 years. Between 2015 and 2050, the proportion of the global population aged over 60 years will nearly double, from 12% to 22%.

Diabetic Retinopathy Market Report Highlights:

  • Non-proliferative diabetic retinopathy accounted for the largest share, by type, in 2023. The presence of large number of patients within the bracket of less than 10 years of diabetic history contributed to the large size of this segment.
  • Anti-VEGF segment accounted for the largest share, by management, in 2023. High applicability of these drugs in treatment of early diagnosis and mild to moderate cases of non-proliferative DR treatment is among the prime factors leading to segmental growth.
  • The Asia Pacific market is expected to grow with the highest CAGR over the forecast period. Large population base in this region, high prevalence of diabetes, and rising geriatric population are likely to bolster the market.
Show more
Product Code: 978-1-68038-466-6

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Management
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Management outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Diabetic Retinopathy Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of diabetes
      • 3.2.1.2. Growing geriatric population
      • 3.2.1.3. Increasing prevalence of blindness due to diabetes
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Lack of accurate diagnosis
      • 3.2.2.2. Adverse effect on treatment
  • 3.3. Diabetic Retinopathy Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Diabetic Retinopathy Market: Type Estimates & Trend Analysis

  • 4.1. Type Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Diabetic Retinopathy Market by Type Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Proliferative Diabetic Retinopathy
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Non-proliferative Diabetic Retinopathy
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Diabetic Retinopathy Market: Management Estimates & Trend Analysis

  • 5.1. Management Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Diabetic Retinopathy Market by Management Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Anti-VEGF
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Intraocular Steroid Injection
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Laser Surgery
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Vitrectomy
      • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Diabetic Retinopathy Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/ reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/ reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework/ reimbursement structure
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework/ reimbursement structure
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework/ reimbursement structure
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Mexico
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.3. Argentina
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework/ reimbursement structure
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework/ reimbursement structure
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework/ reimbursement structure
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework/ reimbursement structure
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework/ reimbursement structure
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Bayer AG
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. ABBVIE INC.
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Novartis AG
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Oxurion NV
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Sirnaomics
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Alimera Sciences
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Ampio Pharmaceuticals Inc.
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. BCNPeptides
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Kowa Company Ltd.
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. Genentech, Inc.
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Product benchmarking
      • 7.3.13.4. Strategic initiatives
Show more
Product Code: 978-1-68038-466-6

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America refurbished MRI systems market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 4 North America refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 5 U.S. refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 6 U.S. refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 7 Canada refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 8 Canada refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 9 Europe refurbished MRI systems market, by region, 2018 - 2030 (USD Million)
  • Table 10 Europe refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 11 Europe refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 12 Germany refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 13 Germany refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 14 UK refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 15 UK refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 16 France refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 17 France refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 18 Italy refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 19 Italy refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 20 Spain refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 21 Spain refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 22 Denmark refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 23 Denmark refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 24 Sweden refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 25 Sweden refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 26 Norway refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Norway refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific refurbished MRI systems market, by region, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 31 China refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 32 China refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 33 Japan refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 34 Japan refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 35 India refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 36 India refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 37 South Korea refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 38 South Korea refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 39 Australia refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 40 Australia refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 41 Thailand refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 42 Thailand refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 43 Latin America refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 44 Latin America refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 45 Brazil refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 46 Brazil refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 47 Mexico refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 48 Mexico refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 49 Argentina refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 50 Argentina refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 51 MEA refurbished MRI systems market, by region, 2018 - 2030 (USD Million)
  • Table 52 MEA refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 53 MEA refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 54 South Africa refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 55 South Africa refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 56 Saudi Arabia refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 58 UAE refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 59 UAE refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 60 Kuwait refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 61 Kuwait refurbished MRI systems market, by management, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Refurbished MRI systems market: market outlook
  • Fig. 14 Refurbished MRI systems competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Refurbished MRI systems market driver impact
  • Fig. 20 Refurbished MRI systems market restraint impact
  • Fig. 21 Refurbished MRI systems market strategic initiatives analysis
  • Fig. 22 Refurbished MRI systems market: Type movement analysis
  • Fig. 23 Refurbished MRI systems market: Type outlook and key takeaways
  • Fig. 24 Proliferative diabetic retinopathy market estimates and forecast, 2018 - 2030
  • Fig. 25 Non-proliferative diabetic retinopathy estimates and forecast, 2018 - 2030
  • Fig. 26 Refurbished MRI systems Market: Management movement Analysis
  • Fig. 27 Refurbished MRI systems market: Management outlook and key takeaways
  • Fig. 28 Anti-VEGF market estimates and forecasts, 2018 - 2030
  • Fig. 29 Laser surgery market estimates and forecasts,2018 - 2030
  • Fig. 30 Vitrectomy market estimates and forecasts,2018 - 2030
  • Fig. 31 Global refurbished MRI systems market: Regional movement analysis
  • Fig. 32 Global refurbished MRI systems market: Regional outlook and key takeaways
  • Fig. 33 Global refurbished MRI systems market share and leading players
  • Fig. 34 North America market share and leading players
  • Fig. 35 Europe market share and leading players
  • Fig. 36 Asia Pacific market share and leading players
  • Fig. 37 Latin America market share and leading players
  • Fig. 38 Middle East & Africa market share and leading players
  • Fig. 39 North America: SWOT
  • Fig. 40 Europe SWOT
  • Fig. 41 Asia Pacific SWOT
  • Fig. 42 Latin America SWOT
  • Fig. 43 MEA SWOT
  • Fig. 44 North America, by country
  • Fig. 45 North America
  • Fig. 46 North America market estimates and forecasts, 2018 - 2030
  • Fig. 47 U.S.
  • Fig. 48 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 49 Canada
  • Fig. 50 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 51 Europe
  • Fig. 52 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 53 UK
  • Fig. 54 UK market estimates and forecasts, 2018 - 2030
  • Fig. 55 Germany
  • Fig. 56 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 57 France
  • Fig. 58 France market estimates and forecasts, 2018 - 2030
  • Fig. 59 Italy
  • Fig. 60 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 61 Spain
  • Fig. 62 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 63 Denmark
  • Fig. 64 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 65 Sweden
  • Fig. 66 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 67 Norway
  • Fig. 68 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 69 Asia Pacific
  • Fig. 70 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 71 China
  • Fig. 72 China market estimates and forecasts, 2018 - 2030
  • Fig. 73 Japan
  • Fig. 74 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 75 India
  • Fig. 76 India market estimates and forecasts, 2018 - 2030
  • Fig. 77 Thailand
  • Fig. 78 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 79 South Korea
  • Fig. 80 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 81 Australia
  • Fig. 82 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 83 Latin America
  • Fig. 84 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 85 Brazil
  • Fig. 86 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 87 Mexico
  • Fig. 88 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 89 Argentina
  • Fig. 90 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 91 Middle East and Africa
  • Fig. 92 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 93 South Africa
  • Fig. 94 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 95 Saudi Arabia
  • Fig. 96 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 97 UAE
  • Fig. 98 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 99 Kuwait
  • Fig. 100 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 101 Market share of key market players - Diabetic retinopathy market
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!